Filing Details
- Accession Number:
- 0001288123-10-000074
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2010-10-28 15:04:53
- Reporting Period:
- 2010-10-26
- Filing Date:
- 2010-10-28
- Accepted Time:
- 2010-10-28 15:04:53
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1098972 | Antigenics Inc | AGEN | Biological Products, (No Disgnostic Substances) (2836) | 061562417 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1369453 | Kerry Wentworth | C/O Antigenics Inc. 162 Fifth Ave., Suite 900 New York NY 10010 | Vp, Clin, Reg & Quality | No | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2010-10-26 | 4,165 | $0.98 | 148,253 | No | 4 | A | Direct | |
Common Stock | Disposition | 2010-10-26 | 4,165 | $0.97 | 144,088 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | A | Direct | |
No | 4 | S | Direct |
Footnotes
- Represents settlement of restricted stock awarded on January 26, 2010.
- Represents sale of shares obtained from the vesting of the restricted stock awarded on January 26, 2010. This sale was made through a 10b5-1 trading plan.